Artificial tear for Dry Eye Syndrome
This trial will evaluate the effectiveness of a new, higher concentration cyclosporine eye drop in treating dry eye, compared to the current standard of care.
- Dry Eye Syndrome
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA given clearance to Artificial tear for consumer use?
"The safety of artificial tear has been thoroughly assessed, thus receiving a score of 3. Such a high rating is attributed to this being an FDA-approved phase 4 trial."
Are applications presently being accepted for this scientific experiment?
"This experiment is no longer recruiting patients, in spite of having been posted on the clinicaltrials.gov website on November 1st 2022 and last modified September 7th 2022. Nevertheless, there are 149 medical trials currently accepting memberships into their studies."
What other empirical investigations involving Artificial tear have been conducted?
"Currently, there are 67 trials in progress examining the potential of Artificial tear. 12 of these investigations have reached Phase 3 and most originate from Aurora, Colorado. However, across 470 separate medical sites around the world, this drug is being tested for safety and efficacy."
How many participants is the trial accommodating?
"Sadly, this trial is no longer recruiting. The first post was on November 1st 2022 and the study's last edit occured on September 7th 2022. If you are searching for other medical trials related to dry eyes or artifical tears, there are currently 82 studies and 67 studies respectively that are still accepting participants."